Metabolism of Eight Model Pharmaceutical Compounds in Rat and Human HepatoPac Versus Liver Microsomes and Suspension Hepatocyte Platforms
Poster Oct 22, 2014
Julius O. Enoru, William DeMaio, Adiba Watanyar, Kenneth Draper, Amanda Moore & Okey Ukairo
In vitro metabolism evaluations for compounds in early development are typically conducted using liver microsomes and suspension hepatocytes. While these systems have been serving the drug development community, they have their limitations, with examples of "metabolite surprises" - where metabolites, which were not predicted or observed in vitro or in vivo during pre-clinical studies, were observed in the clinic. Such surprises can have a significant impact on the timeline of a drug development program and has prompted investigations aimed at developing in vitro systems that can more accurately predict human in vivo metabolism. In this study, the metabolite profile of eight model pharmaceutical compounds with various biotransformation pathways was investigated using a functionally stable model of primary hepatocytes [micropatterned co-cultures (MPCCs)] (HepatoPac®) in parallel with the traditional liver microsomal and suspension hepatocyte systems. Incubations were performed for 0 and 60 min in liver microsomes, 0 and 2 hr in suspension hepatocytes and 0, 4 hr, 2 days and 7 days in MPCCs. Metabolites were identified by LC/MS employing a narrow range of chromatographic conditions, representative of drug metabolism screening in an early development setting. Preliminary results show that MPCCs are more metabolically active than the traditional platforms, based on greater disappearance of test article and formation of metabolites. Formation of metabolites from non-P450 mediated reactions, especially UGTs, and secondary metabolites appear to be more predominant in MPCCs. The results from this investigation support the usefulness of MPCCs for metabolite profiling studies with the potential of eliminating "metabolite surprises." MPCCs also provide the advantage that the cells maintain metabolic activity over an extended period in culture, which probably explains why secondary metabolites were more abundantly generated in this system.
Proteomics and Substrate Based MS Imaging of Xenobiotic Metabolising Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent ModelPoster
Untargeted proteomics analysis showed that human skin and a commercially available living skin equivalent model exhibit a similar distribution of xenobiotic metabolising enzymes. A new technique, substrate based mass spectrometry imaging (SB-MSI) was developed during this study.READ MORE
Development and Assessment of Non-Infected and Infected Skin Models Using MALDI-MSIPoster
Infections have detrimental effects on wound healing leading to chronic wound formation. The use of labskin,a living skin model, in combination with mass spectrometry imaging, provides a good model for assessing wound healing factors.READ MORE
Overcoming the Challenges of Analysing Ionic Polar Pesticides in FoodPoster
Here, the novel application of the Waters’ Torus DEA column is presented, showing the improved performance of a UPLC-MS/MS method for the underivatised
analysis of glyphosate and a selection of other anionic pesticides.